Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-010985
Filing Date
2025-04-17
Accepted
2025-04-17 18:50:22
Documents
1
Period of Report
2025-04-15

Document Format Files

Seq Description Document Type Size
1 form4-04172025_060419.html 4  
1 form4-04172025_060419.xml 4 7971
  Complete submission text file 0001415889-25-010985.txt   9652
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TVARDI THERAPEUTICS, INC. 3 SUGAR CREEK CTR BLVD, STE 525 SUGAR LAND TX 77478
Business Address
O'Brien Stephen Paul (Reporting) CIK: 0002064889 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 25848826